Note: Ingredients listed on restricted chemical lists
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
≤10
EC/CAS
209-008-0/552-30-7
Name of the chemical
Benzene-1,2,4-tricarboxylic acid 1,2-anhydride
Concentration
<1
General Information
Revision date
2023-02-23
Product name
Primax Miles AW (C062)
Emergency telephone
224 919 293, 46922 3 33442
Icons in SDS
Company Information
company name
JOTUN CZECH a.s
e-mail address of the competent person responsible for the Safety Data Sheet
SDSJotun@jotun.no, sdsjotun@jotun.com
GHS Information
Signal word
No signal word
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
No signal word.
Hazard statements
No known significant effects or critical hazards.
Precautionary statements
General : Not applicable.
Prevention
Not applicable.
Response
Not applicable.
Storage
Not applicable.
Disposal
Not applicable.
Supplemental label elements
EUH208 - Contains benzene-1,2,4-tricarboxylic acid 1,2-anhydride. May produce an allergic reaction. EUH210 - Safety data sheet available on request. EUH212 - Warning! Hazardous respirable dust may be formed when used. Do not breathe dust.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Not classified. The product is not classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 11 for more detailed information on health effects and symptoms.
